Lung cancer screening indications and consensus guidelines

16^th Global Annual Oncologists Meeting

April 24-25, 2017 Dubai, UAE

Ali Aldameh

Tawam Hospital, UAE

Scientific Tracks Abstracts: J Cancer Sci Ther

Abstract :

Lung cancer is an aggressive and heterogeneous disease. Advances in surgical, radiotherapeutic, and chemotherapeutic approaches have been made, but the long-term survival rate remains low. After the Surgeon General's 1964 report on smoking and health, mortality from lung cancer among men peaked and then fell; among women, the peak occurred later and a slight decline has occurred more recently. Lung cancer screening reduces mortality from lung cancer. We will discuss recent updates on guidelines, lung cancer screening and management of early detected lung cancer.

Biography :

Ali Aldameh is Certified in Surgery, Thoracic Oncology and Thoracic Surgery. He received his Advanced Thoracic Surgical Education in Harvard Medical School, Boston USA at Brigham and Women's Hospital. Following that, he completed an advanced fellowship in Minimally Invasive Thoracic and Foregut Surgery at Harvard Medical School. He was mentored by US leaders in their field of Thoracic Surgery who followed the tradition of pioneers in their fields, including Dr. Pearson in Toronto, Luketich in Pittsburgh, Orringer. He has closely worked with Dr. Sugarbaker the late President of the American Association of Thoracic Surgery, Dr. Scott Swanson a World Leader in VATS Surgery and Dr. Steve Menzer, an expert in Lung Surgery and Esophagectomy in North America.

Email: dralinz@gmail.com